Interview Series 20th March 2026
From the helm: Amplia (ASX:ATX), CEO & MD, Christopher Burns & Bell Potter Analyst, Thomas Wakim.
In this episode of From the Helm, Grady is joined by Amplia Therapeutics (ASX:ATX) CEO & MD Dr Christopher Burns & Bell Potter Analyst Thomas Wakim to unpack the ongoing clinical trials for their prospective treatment drug for pancreatic cancer, and its substantial market opportunities in the US.
-
Interview Series 18 Oct 2024
From the helm: Findi Ltd (ASX:FND), Chairman, Nicholas Smedley
-
Interview Series 18 Oct 2024
From the helm: Tower Ltd (ASX:TWR), CEO, Blair Turnbull
-
Interview Series 18 Oct 2024
From the helm: Botanix Phamaceuticals (ASX:BOT) CEO, Dr Howie McKibbon
-
Interview Series 18 Oct 2024
From the helm: Elsight Ltd (ASX:ELS), CEO, Yoav Amitai
-
_600_338.jpg)
Interview Series 24 May 2024
From the helm: Clarity Pharmaceuticals Executive Chairman, Alan Taylor
-
Interview Series 13 Dec 2023
Morning Bell - Grady Wulff
-
Interview Series 13 Dec 2023
Morning Bell - Grady Wulff
-
Interview Series 18 Jul 2023
From the helm: DroneShield (ASX:DRO) CEO, Oleg Vornik
-
-min_600_399.png)
Interview Series 17 May 2023
From the helm: Liontown Resources (ASX:LTR) Chairman, Tim Goyder
-
-min_600_338.png)
Interview Series 23 Feb 2023
Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2
-
_600_338.png)
Interview Series 23 Feb 2023
Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 1
-
Interview Series 8 Dec 2022
From the helm: Pilbara Minerals (ASX:PLS) Managing Director & CEO, Dale Henderson